Sharing of an HLA-B27-restricted H-Y antigen between rat and mouse
- PMID: 8344721
- DOI: 10.1007/BF00210477
Sharing of an HLA-B27-restricted H-Y antigen between rat and mouse
Retraction in
-
Sharing of an HLA-B27-restricted H-Y antigen between rat and mouse.Immunogenetics. 2000 Jan;51(1):82. Immunogenetics. 2000. PMID: 10702025 No abstract available.
Abstract
The purpose of this work was twofold: 1) to learn whether rats transgenic for HLA-B27 and the human beta 2-microglobulin gene HB2M can mount B27-restricted cytolytic T lymphocyte (CTL) responses to the male H-Y antigen, and 2) to learn whether such CTLs would recognize both rat and mouse H-Y in the context of HLA-B27. Female rats of the B27/HB2M transgenic line 21-4L were primed in vivo with cells from males of the same line. CTL effectors were generated from lymph node cells of these females following culture with irradiated antigen-presenting cells from either male 21-4L rats or male mice of the B27/HB2M transgenic 56-3 line. The CTLs showed male-specific, B27-specific lysis of both rat and mouse targets. Lysis of B27 targets was inhibitable by monoclonal antibodies specific for B27 or rat CD8. Specific lysis of male B27 rat and mouse targets was inhibitable equally by either rat or mouse male B27 cold targets, but not significantly by female or nontransgenic cold targets. The B27-restricted CTLs neither recognized nor were inhibited by B27+ or B27- male or female human targets. These results demonstrate that CD8+, B27-restricted, anti-H-Y CTLs recognize an evolutionarily conserved H-Y peptide antigen in both rats and mice. In addition, they establish the transgenic rat as a model system for examining the T-cell response to antigen presented by class I HLA molecules.
Comment in
-
Findings.NIH Guide Grants Contracts (Bethesda). 2000 Sep 12:OD-00-052. NIH Guide Grants Contracts (Bethesda). 2000. PMID: 12458560 Free PMC article. No abstract available.
-
Findings of Scientific Misconduct.Fed Regist. 2000 Sep 11;65(176):54852-54853. Fed Regist. 2000. PMID: 27737090 Free PMC article. No abstract available.
Similar articles
-
Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat.Infect Immun. 1999 Aug;67(8):3773-9. doi: 10.1128/IAI.67.8.3773-3779.1999. Infect Immun. 1999. PMID: 10417137 Free PMC article.
-
Recognition of chlamydial antigen by HLA-B27-restricted cytotoxic T cells in HLA-B*2705 transgenic CBA (H-2k) mice.Arthritis Rheum. 1997 May;40(5):945-54. doi: 10.1002/art.1780400524. Arthritis Rheum. 1997. PMID: 9153558
-
Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease.J Immunol. 1996 Feb 15;156(4):1661-7. J Immunol. 1996. Retraction in: J Immunol. 1999 Nov 15;163(10):5741. PMID: 8568273 Retracted.
-
Arthritis in HLA-B27 transgenic animals.Am J Med Sci. 1998 Oct;316(4):250-6. doi: 10.1097/00000441-199810000-00005. Am J Med Sci. 1998. PMID: 9766486 Review.
-
Colitis in HLA-B27/beta 2 microglobulin transgenic rats.Int Rev Immunol. 2000;19(1):39-50. doi: 10.3109/08830180009048388. Int Rev Immunol. 2000. PMID: 10723676 Review.
Cited by
-
Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment.J Exp Med. 1993 Nov 1;178(5):1607-16. doi: 10.1084/jem.178.5.1607. J Exp Med. 1993. PMID: 8228809 Free PMC article.
-
The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats.J Exp Med. 1998 Sep 7;188(5):877-86. doi: 10.1084/jem.188.5.877. J Exp Med. 1998. PMID: 9730889 Free PMC article.
-
Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat.Infect Immun. 1999 Aug;67(8):3773-9. doi: 10.1128/IAI.67.8.3773-3779.1999. Infect Immun. 1999. PMID: 10417137 Free PMC article.
-
Experimental spondyloarthropathy in HLA-B27 transgenic rats.Clin Rheumatol. 1996 Jan;15 Suppl 1:22-7. doi: 10.1007/BF03342640. Clin Rheumatol. 1996. PMID: 8835497 Review.
-
Novel experimental approaches in the study of the immunopathology in inflammatory bowel disease.J Mol Med (Berl). 1995 Mar;73(3):133-40. doi: 10.1007/BF00198241. J Mol Med (Berl). 1995. PMID: 7633950 Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials